BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34192412)

  • 21. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial.
    Lee DH; Li K; Suh DH
    Br J Dermatol; 2008 May; 158(5):1069-76. PubMed ID: 18363758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis.
    El-Batawy MM; Bosseila MA; Mashaly HM; Hafez VS
    J Dermatol Sci; 2009 May; 54(2):76-87. PubMed ID: 19303745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of pimecrolimus cream in disorders other than atopic dermatitis.
    Day I; Lin AN
    J Cutan Med Surg; 2008; 12(1):17-26. PubMed ID: 18258153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study.
    Hu W; Xu Y; Ma Y; Lei J; Lin F; Xu AE
    Clin Drug Investig; 2019 Dec; 39(12):1233-1238. PubMed ID: 31522334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
    Chen SL; Yan J; Wang FS
    J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
    Stuetz A; Baumann K; Grassberger M; Wolff K; Meingassner JG
    Int Arch Allergy Immunol; 2006; 141(3):199-212. PubMed ID: 16926539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy.
    Werfel T
    J Dtsch Dermatol Ges; 2009 Sep; 7(9):739-42. PubMed ID: 19650820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Topical Calcineurin Inhibitors in Oral Lichen Planus.
    Sotoodian B; Lo J; Lin A
    J Cutan Med Surg; 2015; 19(6):539-45. PubMed ID: 26088501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosaceiform dermatitis associated with topical tacrolimus treatment.
    Fujiwara S; Okubo Y; Irisawa R; Tsuboi R
    J Am Acad Dermatol; 2010 Jun; 62(6):1050-2. PubMed ID: 20466178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis.
    Yin ZQ; Zhang WM; Song GX; Luo D
    J Dermatol; 2012 Jun; 39(6):520-6. PubMed ID: 22409418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical calcineurin inhibitors and risk of lymphoma: a systematic review and meta-analysis.
    Wu PC; Huang IH; Liu CW; Huang YC
    J Dtsch Dermatol Ges; 2021 Sep; 19(9):1265-1269. PubMed ID: 34390192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pimecrolimus vs. tacrolimus for the topical treatment of unresponsive oral erosive lichen planus: a 8 week randomized double-blind controlled study.
    Arduino PG; Carbone M; Della Ferrera F; Elia A; Conrotto D; Gambino A; Comba A; Calogiuri PL; Broccoletti R
    J Eur Acad Dermatol Venereol; 2014 Apr; 28(4):475-82. PubMed ID: 23451852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
    Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
    Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Hultsch T; Kapp A; Spergel J
    Dermatology; 2005; 211(2):174-87. PubMed ID: 16088174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus-induced rosacea-like dermatitis: a clinical analysis of 16 cases associated with tacrolimus ointment application.
    Teraki Y; Hitomi K; Sato Y; Izaki S
    Dermatology; 2012; 224(4):309-14. PubMed ID: 22626964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antipruritic effects of pimecrolimus and tacrolimus].
    Ständer S; Luger TA
    Hautarzt; 2003 May; 54(5):413-7. PubMed ID: 12719860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of granulomatous rosacea successfully treated with pimecrolimus cream.
    Gül U; Gönül M; Kiliç A; Koçak O; Aslan E; Ergül G; Kulaçoğlu S
    J Dermatolog Treat; 2008; 19(5):313-5. PubMed ID: 18608739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC; Qureshi AA
    Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis.
    Chamani G; Rad M; Zarei MR; Lotfi S; Sadeghi M; Ahmadi Z
    Int J Dermatol; 2015 Sep; 54(9):996-1004. PubMed ID: 26204904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of topical administration of tacrolimus in oral lichen planus: An updated systematic review and meta-analysis of randomized controlled trials.
    Su Z; Hu J; Cheng B; Tao X
    J Oral Pathol Med; 2022 Jan; 51(1):63-73. PubMed ID: 34133803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.